Dr. Charles Maxwell Medert, MD

Dr. Medert practices at Austin Eye Laser and Surgicenter in Austin, Texas.

Dr. Medert's NPI, 1487195608, was assigned on March 20, 2017. Dr. Medert graduated from Emory School of Medicine in 2017. Dr. Medert holds Texas license U2087.

Dr. Medert's primary practice is Austin Eye Laser and Surgicenter, at 11901 Jollyville Rd, Austin, TX 78759 in Travis County. The practice phone is (512) 250-2020.

Dr. Medert's primary practice is Austin Eye Laser and Surgicenter in Austin, Texas. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Dr. Medert to 2 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Medert practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Medert's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Medert is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Medert's licenses on file in 2 states: Texas and Illinois.

Dmand AI lists cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eyelid inflammation, glaucoma and glaucoma surgery among the conditions Dr. Medert treats.

CMS data shows 1,432 Medicare services from Dr. Medert across 12 procedure codes in 2024, for 463 Medicare patients. Medicare paid $114,504 for them.

CMS counts 463 Medicare patients who saw Dr. Medert in 2024. The largest group is 65 to 74, with 239 patients. 75% of them have high cholesterol, and 64% have high blood pressure. Their average risk score is 0.85, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Medert's median patient age at 71, with 55% women.

In 2024, Dr. Medert wrote 943 Medicare Part D claims for 243 patients. 60% of them were for generic drugs. CMS names the drug for 853 of them, across 17 drugs with 11 or more claims each, at $130,961 in total drug cost. In 2023, CMS named 898 claims across 14 drugs.

Dr. Medert accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 189 procedures of cataract surgery by Dr. Medert, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 15 papers to Dr. Medert, published from 2015 to 2021. 2020 was the busiest year, with 5. The most frequent topics are Telemedicine, Delivery of Health Care and Bufanolides. Dr. Medert has published most often in Ophthalmology. Dr. Medert's most frequent co-authors are Mary Gerard Lynch, MD, April Yauguang Maa, MD and Ta Chen Peter Chang, MD.

CMS Open Payments shows 92 general payments to Dr. Medert from 14 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 45% of the total. Bausch & Lomb Americas Inc. paid the most, $8,226.

Dmand AI lists 3 awards for Dr. Medert, most recently Bucksbaum Institute Associate Junior Faculty Scholar in 2021.

Dr. Medert graduated from Emory School of Medicine in 2017. Dr. Medert is a member of AAO.

Dr. Medert is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Cigna. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.